New drug tested for Tough-to-Treat blood cancers
NCT ID NCT04362007
Summary
This study tested a new drug called ASTX660 for people with T-cell lymphoma that has returned or not improved with other treatments. The main goals were to find a safe dose and see how well the drug worked. The trial was small and ended early, so it was a first step in understanding the drug's potential.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RELAPSED OR REFRACTORY PERIPHERAL T-CELL LYMPHOMA(PTCL),CUTANEOUS T-CELL LYMPHOMA(CTCL),ADULT T-CELL LEUKEMIA/LYMPHOMA(ATLL) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Yamagata University Hospital
Yamagata, Japan
Conditions
Explore the condition pages connected to this study.